Early prediction of sustained viral responder and non-responder during interferon and ribavirin combination therapy in chronic hepatitis C.
Nakamura
Hideji
H
Division of Hepatobiliary and Pancreatic Medicine, Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.